RNTX: aileronrx.com Expected earnings per share growth for next year

Public company logo of Rein Therapeutics Inc (RNTX)

Rein Therapeutics Inc (RNTX) is subject to the impact of cross-border financial restrictions and sanctions, which complicate testing and the import of components. The history of consensus earnings estimates for the coming year visualizes these challenges, with the indicator level standing at -1.10. High molecular biology costs and strict FDA oversight create significant barriers, while the current pipeline restructuring amplifies the company's risk volatility.

Rein Therapeutics Inc. (RNTX): Net earnings per share change forecast for next year from 07/04/2022 to 11/18/2026

Analytical breakdowns and data insights for company Rein Therapeutics Inc. (RNTX)

- share price and consensus valuation forecast:
Fundamental company valuation:RNTX, aileronrx.com
Finished products of Rein Therapeutics

For an investor assessing the issuer's financial stability, this indicator serves as a barometer of market optimism. The metric captures the trend of the consensus forecast for earnings per share growth, reflecting shifting analyst expectations regarding the business's future profitability. For Rein Therapeutics Inc (RNTX), the EPS growth target for the coming year depends directly on the success of oncology drug development and the effectiveness of strategic partnerships.

Analysis of competing companies

VRTX (Vertex) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year ALNY (Alnylam)|Expected earnings per share growth for next year INSM (Insmed)|UTHR (United Therapeutics Corp) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year BioMarin BMRN|BBIO (BridgeBio Pharma Inc) - Net earnings per share change forecast for next year|BGM Group Ltd - Earnings growth forecast for next year|Expected earnings per share trend next year COGT (Cogent Biosciences)|XERS: Earnings growth forecast for next year|Keros Therapeutics Inc (KROS) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Arcturus Pharma|ETON: Expected earnings per share trend next year|Net earnings per share growth forecast for next year kamada.com (KMDA)|Expected earnings per share growth for next year Fulcrum Therapeutics FULC|Earnings growth forecast for next year ABEO (Abeona Therapeutics, Inc.)|Earnings growth forecast for next year Mereo BioPharma MREO|PLX - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year PLRX|Applied Therapeutics (APLT) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Gelteq Limited Inc (GELS)|Expected earnings per share growth for next year AYTU|Expected net earnings per share growth next year chemomab.com CMMB|Expected earnings per share growth for next year SRXH (SRx Health Solutions Inc)|PLRZ - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Aeterna Zentaris AEZS|Cyclo Therapeutics, Inc. (CYTH) - Expected net earnings per share growth next year|INZY - Net earnings per share growth forecast for next year|Expected earnings per share trend next year RPHM (Reneo Pharmaceuticals Inc.)|COSCIENS Biopharma Inc. (CSCI) - Net earnings per share growth forecast for next year